BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25611590)

  • 1. In vitro and in vivo identification of metabolites of magnoflorine by LC LTQ-Orbitrap MS and its potential pharmacokinetic interaction in Coptidis Rhizoma decoction in rat.
    Xue B; Zhao Y; Miao Q; Miao P; Yang X; Sun G; Su J; Ye J; Wei B; Zhang Y; Zhang Y
    Biomed Chromatogr; 2015 Aug; 29(8):1235-48. PubMed ID: 25611590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Intestinal Absorption and Metabolism of Magnoflorine and its Potential Interaction in Coptidis Rhizoma Decoction in Rat.
    Xue B; Zhao Y; Su J; Miao Q; Miao P; Chen N; Wang Z; Zhang Y; Ma S
    Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):281-293. PubMed ID: 27209587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of coexisting components in Coptidis Rhizoma on excretion of magnoflorine in rat bile, urine, and feces].
    Xue BJ; Zhao WW; Sun XR; Zhang Z; Chen JH; Zhang YJ
    Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(14):3908-3914. PubMed ID: 35850849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the PK profiles of magnoflorine and its potential interaction in Cortex phellodendri decoction by LC-MS/MS.
    Tian X; Li Z; Lin Y; Chen M; Pan G; Huang C
    Anal Bioanal Chem; 2014 Jan; 406(3):841-9. PubMed ID: 24337185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profile of Rhizoma coptidis in human plasma determined using ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry.
    Zhang QS; Wang GW; Han ZQ; Chen XM; Na R; Jin H; Li P; Bu R
    Rapid Commun Mass Spectrom; 2018 Jan; 32(1):63-73. PubMed ID: 28926137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of magnoflorine in Coptidis Rhizoma and Phellodendri Chinensis Cortex by LC-MS].
    Fan S; Yu D; Gu Y; Zhang M; Zhang L; Li G
    Zhongguo Zhong Yao Za Zhi; 2010 Dec; 35(24):3322-4. PubMed ID: 21438400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased systemic exposure to rhizoma coptidis alkaloids in lipopolysaccharide-pretreated rats attributable to enhanced intestinal absorption.
    Ma BL; Yao MK; Zhong J; Ma YM; Gao CL; Wu JS; Qiu FR; Wang CH; Wang XH
    Drug Metab Dispos; 2012 Feb; 40(2):381-8. PubMed ID: 22086980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of Rhizoma coptidis in Human Urine by Ultra-High-Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry.
    Zhang Q; Wang G; Chen X; Han Z; Chen X; Na R; Jin H; Li P; Bu R
    Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):441-452. PubMed ID: 29450708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differences in effective mechanisms of Coptidis Rhizoma and bile processed Coptidis Rhizoma on heat syndrome based on urinary metabonomics].
    Wang J; Chen Y; Yuan ZM; Lv J
    Zhongguo Zhong Yao Za Zhi; 2016 Jul; 41(14):2638-2645. PubMed ID: 28905599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive characterization of Epimedium-Rhizoma drynariae herb pair in rat plasma, urine, and feces metabolic profiles by UHPLC-Q-Orbitrap HRMS combined with diagnostic extraction strategy and multicomponent pharmacokinetic study by UHPLC-MS/MS.
    Li Q; Ren M; Liu Y; Qin F; Xiong Z
    Anal Bioanal Chem; 2024 Jun; 416(14):3415-3432. PubMed ID: 38649516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic screening and characterization of absorbed constituents and in vivo metabolites in rats after oral administration of Rhizoma coptidis using UPLC-Q-TOF/MS.
    Feng X; Wang K; Hu X; Chai L; Cao S; Ding L; Qiu F
    Biomed Chromatogr; 2020 Oct; 34(10):e4919. PubMed ID: 32533560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of global metabolic profile of Zhi-Zi-Hou-Po decoction in rat bile, urine and feces after oral administration based on a strategy combining LC-MS and chemometrics.
    Luo K; Shi Q; Feng F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():260-272. PubMed ID: 27838179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influences of Fructus evodiae pretreatment on the pharmacokinetics of Rhizoma coptidis alkaloids.
    Ma BL; Yao MK; Han XH; Ma YM; Wu JS; Wang CH
    J Ethnopharmacol; 2011 Oct; 137(3):1395-401. PubMed ID: 21855623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolites of protoberberine alkaloids in human urine following oral administration of Coptidis Rhizoma decoction.
    Yang Y; Kang N; Xia H; Li J; Chen L; Qiu F
    Planta Med; 2010 Nov; 76(16):1859-63. PubMed ID: 20549593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic profiling integrated with pharmacokinetics to reveal the material basis of Xiaokeyinshui extract combination in the treatment of type 2 diabetes in rats.
    Tong QL; Luo D; Xiang ZN; Zhang YL; He JX; Hu ZF; Xia RF; Wu JL; Fu XN; Li Q; Peng HM; Huang R; Wan LS; Chen JC; Fang JB
    J Pharm Biomed Anal; 2023 Feb; 225():115224. PubMed ID: 36603394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro and In vivo effects of six Coptidis alkaloids on liver microsomes UGTs and UGT1A1 activities in rats and mice].
    Zhao YY; Miao PP; Miao Q; Guo CE; Chen HY; Chen N; Zhang YJ; Ma SC
    Zhongguo Zhong Yao Za Zhi; 2016 Jan; 41(2):309-313. PubMed ID: 28861978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of Coptidis Rhizoma and Aconiti Kusnezoffii Radix on cell differentiation in lewis lung cancer].
    Zhao B; Hou XD; Li H; Qi XX; Li GG; Liu LX; Wang P; Du GJ
    Zhongguo Zhong Yao Za Zhi; 2014 Jul; 39(14):2732-8. PubMed ID: 25272505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [iTRAQ technology combined with 2D-LC-MS/MS to analyze effect of Coptidis Rhizoma on cytochrome P450 isoenzyme expression].
    Yang X; Wang QH; Wang M; Wang Y; Yang BY; Kuang HX
    Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(4):731-736. PubMed ID: 28871702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid chromatography/mass spectrometric analysis of rat samples for in vivo metabolism and pharmacokinetic studies of ginsenoside Rh2.
    Qian T; Cai Z; Wong RN; Jiang ZH
    Rapid Commun Mass Spectrom; 2005; 19(23):3549-54. PubMed ID: 16261639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Exploring the mechanism of rhizoma coptidis in treating type II diabetes mellitus based on metabolomics by gas chromatography-mass spectrometry].
    Wang J; Yuan Z; Kong H; Li Y; Lu X; Xu G
    Se Pu; 2012 Jan; 30(1):8-13. PubMed ID: 22667084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.